HIV-2-infected patients survive longer than HIV-1-infected patients
- PMID: 7848600
- DOI: 10.1097/00002030-199411000-00015
HIV-2-infected patients survive longer than HIV-1-infected patients
Abstract
Objective: To compare survival of patients infected with HIV-1 and HIV-2.
Design: Longitudinal follow-up of 175 HIV-1- and 294 HIV-2-infected patients identified in, or referred to a hospital in The Gambia.
Methods: Survival analysis methods were used and the death rate ratios for HIV-2 relative to HIV-1 patients were estimated using proportional hazard regression models that allowed for age, sex and clinical or immunological features.
Results: The overall death rate ratio for HIV-2 relative to HIV-1 was 0.67 [95% confidence interval (CI), 0.49-0.91] when adjusted for age, sex and World Health Organization Bangui clinical classification. When allowing for age, sex and three strata of CD4+ count, the rate ratio was 0.64 (95% CI, 0.43-0.94), and for three strata of beta 2-microglobulin levels 0.60 (95% CI, 0.42-0.84).
Conclusion: Mortality rate in HIV-2-infected patients is approximately two-thirds of that for HIV-1-infected patients.
Similar articles
-
Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.AIDS. 1992 Jul;6(7):685-9. doi: 10.1097/00002030-199207000-00011. AIDS. 1992. PMID: 1354448
-
Predictors of mortality among HIV-infected women in Kigali, Rwanda.Ann Intern Med. 1992 Feb 15;116(4):320-8. doi: 10.7326/0003-4819-116-4-320. Ann Intern Med. 1992. PMID: 1733389
-
9-year HIV-2-associated mortality in an urban community in Bissau, west Africa.Lancet. 1997 Mar 29;349(9056):911-4. doi: 10.1016/S0140-6736(96)04402-9. Lancet. 1997. PMID: 9093252
-
The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.AIDS. 2000 Jun 16;14(9):1147-53. doi: 10.1097/00002030-200006160-00011. AIDS. 2000. PMID: 10894278
-
Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia.AIDS. 2002 Sep 6;16(13):1775-83. doi: 10.1097/00002030-200209060-00010. AIDS. 2002. PMID: 12218389
Cited by
-
Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1.J Virol. 2000 Oct;74(20):9594-600. doi: 10.1128/jvi.74.20.9594-9600.2000. J Virol. 2000. PMID: 11000231 Free PMC article.
-
Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo.J Virol. 2006 Aug;80(15):7316-21. doi: 10.1128/JVI.00604-06. J Virol. 2006. PMID: 16840312 Free PMC article.
-
Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection.J Virol. 2007 May;81(10):5325-30. doi: 10.1128/JVI.02625-06. Epub 2007 Feb 28. J Virol. 2007. PMID: 17329334 Free PMC article.
-
Effect of sex and age on outcomes among HIV-2-infected patients starting antiretroviral therapy in West Africa.AIDS. 2016 Nov 13;30(17):2707-2714. doi: 10.1097/QAD.0000000000001232. AIDS. 2016. PMID: 27536979 Free PMC article.
-
Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses.J Virol. 2007 Dec;81(24):13852-64. doi: 10.1128/JVI.00904-07. Epub 2007 Oct 10. J Virol. 2007. PMID: 17928336 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials